Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration
Recruiting
N/A
Interventional Study
Acute Myocardial Infarction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 100 (estimated)
- Sponsor
- Pharmicell Co., Ltd. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This Long-term follow-up is designed to evaluate the safety of patient with Acute Myocardial Infarction who had administered Hearticellgram-AMI.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Those who had administered Hearticellgram-AMI
2. Those who voluntarily agreed in writing to participate in this investigation
Exclusion Criteria:
\-
Contacts